These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10813287)

  • 1. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
    Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA
    J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
    Falkner D; Wilson J; Medsger TA; Morel PA
    Arthritis Rheum; 1998 Jan; 41(1):74-80. PubMed ID: 9433872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
    J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
    Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
    J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
    Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
    Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.
    Kuwana M; Okano Y; Kaburaki J; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Feb; 42(2):275-84. PubMed ID: 10025921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position 26 of the first domain of the HLA-DQB1 allele in post-silicone implant scleroderma.
    Morse JH; Fotino M; Zhang Y; Flaster ER; Peebles CL; Spiera H
    J Rheumatol; 1995 Oct; 22(10):1872-5. PubMed ID: 8991984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.
    Morel PA; Chang HJ; Wilson JW; Conte C; Saidman SL; Bray JD; Tweardy DJ; Medsger TA
    Hum Immunol; 1994 Jun; 40(2):101-10. PubMed ID: 7928439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
    Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
    J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different distribution of HLA class II and tumor necrosis factor alleles (TNF-308.2, TNFa2 microsatellite) in anti-topoisomerase I responders among scleroderma patients with and without exposure to quartz/metal dust.
    Frank KH; Füssel M; Conrad K; Rihs HP; Koch R; Gebhardt B; Mehlhorn J
    Arthritis Rheum; 1998 Jul; 41(7):1306-11. PubMed ID: 9663489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
    Kuwana M; Feghali CA; Medsger TA; Wright TM
    Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA and autoimmunity in scleroderma (systemic sclerosis).
    Arnett FC
    Int Rev Immunol; 1995; 12(2-4):107-28. PubMed ID: 7650416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.